Humoral rejection of human organ transplants

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Springer Seminars in Immunopathology

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00281-003-0139-xPMID 12955463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection.

  2003cited by this paper
• Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities

  2003cited by this paper
• Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

  2003influential reference
• Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection

  2003cited by this paper
• Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury.

  2002cited by this paper
• Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report.

  2002cited by this paper
• Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis

  2002cited by this paper
• Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.

  2002influential reference
• Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment

  2002cited by this paper
• C4d staining of perioperative renal transplant biopsies1

  2002cited by this paper
• Activation of the Lectin Complement Pathway by H-Ficolin (Hakata Antigen)1

  2002cited by this paper
• Ligation of HLA Class I Molecules on Endothelial Cells Induces Phosphorylation of Src, Paxillin, and Focal Adhesion Kinase in an Actin-Dependent Manner1

  2002cited by this paper
• X-ray crystal structure of the C4d fragment of human complement component C4.

  2002cited by this paper
• Apoptosis and Cellular Activation in the Pathogenesis of Acute Vascular Rejection

  2002cited by this paper
• C4d staining of perioperative renal transplant biopsies.

  2002cited by this paper
• Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.

  2002influential reference
• C4d and the fate of organ allografts.

  2002influential reference
• C4d deposition in acute rejection: an independent long-term prognostic factor.

  2002influential reference
• Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis

  2002cited by this paper
• C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

  2002cited by this paper
• A case of severe C4d-positive kidney allograft dysfunction in the absence of histomorphologic features of rejection.

  2002cited by this paper
• All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies

  2002cited by this paper
• C1‐Inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of h‐DAF transgenic porcine kidneys

  2001cited by this paper
• Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4.

  2001cited by this paper
• Tolerance, Mixed Chimerism, and Chronic Transplant Arteriopathy1 2

  2001cited by this paper
• Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection.

  2001influential reference
• ABO-incompatible heart transplantation in infants.

  2001cited by this paper
• Endothelial cell chimerism after renal transplantation and vascular rejection.

  2001cited by this paper
• Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody.

  2001cited by this paper
• REVERSAL OF STEROID- AND ANTI-LYMPHOCYTE ANTIBODY- RESISTANT REJECTION USING INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN RENAL TRANSPLANT RECIPIENTS

  2001cited by this paper
• Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries.

  2001cited by this paper
• C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption.

  2001cited by this paper
• ACUTE HUMORAL REJECTION IN RENAL ALLOGRAFT RECIPIENTS: I. INCIDENCE, SEROLOGY AND CLINICAL CHARACTERISTICS1

  2001cited by this paper
• Transplant Accommodation in Highly Sensitized Patients: A Potential Role for Bcl‐xL and Alloantibody

  2001cited by this paper
• ABO-incompatible living-donor kidney transplantation in children.

  2001cited by this paper
• Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.

  2001cited by this paper
• Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts.

  2001influential reference
• Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome.

  2000cited by this paper
• Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.

  2000cited by this paper
• Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21).

  2000cited by this paper
• Acute Humoral Xenograft Rejection: Destruction of the Microvascular Capillary Endothelium in Pig-to-Nonhuman Primate Renal Grafts

  2000cited by this paper
• Involvement of antibody-dependent apoptosis in graft rejection.

  2000cited by this paper
• Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients.

  2000cited by this paper
• Clinical importance of HLA-specific and non-HLA-specific antibodies in allogeneic kidney transplantation.

  2000cited by this paper
• Resistance Against the Membrane Attack Complex of Complement Induced in Porcine Endothelial Cells with a Galα(1–3)Gal Binding Lectin: Up-Regulation of CD59 Expression1

  2000cited by this paper
• Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study.

  2000cited by this paper
• Rejection of peritubular capillaries in renal allo‐ and xeno‐grafts

  2000cited by this paper
• Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection.

  1999cited by this paper
• Vascular rejection in cardiac transplantation.

  1999cited by this paper
• Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries.

  1999cited by this paper
• Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.

  1999cited by this paper
• Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation.

  1999cited by this paper
• Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.

  1999cited by this paper
• Humoral immunity in acute cellular rejection after living-donor liver transplantation.

  1999cited by this paper
• Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection.

  1999cited by this paper
• Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes.

  1999cited by this paper
• Peritubular capillary deposition of C4d complement fragment in ABO-incompatible renal transplantation with humoral rejection.

  1999cited by this paper
• Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages.

  1999cited by this paper
• The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation.

  1999cited by this paper
• Coronary artery disease after heart transplantation and its relation to cytomegalovirus.

  1999cited by this paper
• Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action.

  1998cited by this paper
• Macrophage migration inhibitory factor expression in human renal allograft rejection.

  1998cited by this paper
• Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation.

  1998cited by this paper
• An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.

  1998cited by this paper
• Orthotopic heart transplantation in a transgenic pig-to-primate model.

  1998cited by this paper
• Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.

  1998cited by this paper
• Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.

  1997cited by this paper
• Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection.

  1997cited by this paper
• Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice.

  1997cited by this paper
• Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation.

  1997influential reference
• Postoperative production of anti-donor antibody and chronic rejection in renal transplantation.

  1997cited by this paper
• An analysis of monocyte/macrophage subsets and granulocyte-macrophage colony-stimulating factor expression in renal allograft biopsies.

  1996cited by this paper
• Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease.

  1996cited by this paper
• Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema.

  1996influential reference
• Macrophages and chronic renal allograft nephropathy.

  1996cited by this paper
• Clinical manifestation of acute vascular rejection in cardiac transplant recipients

  1995cited by this paper
• THE HUMORAL IMMUNE RESPONSE IN HUMANS FOLLOWING CROSS‐PERFUSION OF PORCINE ORGANS

  1995cited by this paper
• Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.

  1995cited by this paper
• Acute vascular (humoral) rejection in non-OKT3-treated cardiac transplants.

  1995cited by this paper
• Immunoglobulin g lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance

  1995cited by this paper
• Reliability and usefulness of immunofluorescence in heart transplantation.

  1995cited by this paper
• Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.

  1995cited by this paper
• Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

  1994cited by this paper
• Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters. Main antibody reactivity against α‐linked galactose‐containing epitopes

  1994cited by this paper
• THE CLINICAL SIGNIFICANCE OF ALLOSPECIFIC ANTIBODIES AGAINST ENDOTHELIAL CELLS DETECTED WITH AN ANTIBODY‐DEPENDENT CELLULAR CYTOTOXICITY ASSAY FOR VASCULAR REJECTION AND GRAFT LOSS AFTER RENAL TRANSPLANTATION

  1993cited by this paper
• Vascular rejection in heart transplant recipients.

  1993cited by this paper
• Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy.

  1993cited by this paper
• Capillary deposition of C4d complement fragment and early renal graft loss.

  1993cited by this paper
• Vascular rejection in cardiac transplantation: Histologic, immunopathologic, and ultrastructural features.

  1993cited by this paper
• Immunostaining of cardiac biopsy specimens in the diagnosis of acute vascular (humoral) rejection: a control study.

  1993cited by this paper
• Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations.

  1993cited by this paper
• Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients.

  1992cited by this paper
• THE SIGNIFICANCE OF THE ANTI–CLASS I RESPONSE

  1992cited by this paper
• Complement activation in the follicular light zone of human lymphoid tissues.

  1992cited by this paper
• Integrins: versatility, modulation, and signaling in cell adhesion.

  1992cited by this paper
• Value of confirmation of chlamydiazyme enzyme immunoassay results in the detection ofChlamydia trachomatis

  1992cited by this paper
• Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies.

  1992cited by this paper
• Intertubular capillary changes in kidney allografts: a morphologic investigation on 61 renal specimens.

  1992cited by this paper
• Vascular rejection and its relationship to allograft coronary artery disease.

  1992cited by this paper
• Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.

  1992cited by this paper

• Human cytomegalovirus and Epstein–Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients

  2023cites this paper
• Mouse Sertoli Cells Inhibit Humoral-Based Immunity

  2022cites this paper
• Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps

  2022cites this paper
• Phosphorylated S6 ribosomal protein expression by immunohistochemistry correlates with de novo donor-specific HLA antibodies in lung allograft recipients.

  2021cites this paper
• Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection

  2020cites this paper
• Immunogenicity analysis of decellularized cardiac scaffolds after transplantation into rats.

  2019cites this paper
• LIVER AND KIDNEY FUNCTION AFTER PEDIATRIC LIVER TRANSPLANTATION

  2019cites this paper
• Generation of hypoimmunogenic human pluripotent stem cells

  2019cites this paper
• Antibody-Mediated Rejection

  2017cites this paper
• Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.

  2017cites this paper
• Maintenance immunosuppressants in the management of antibody-mediated renal allograft rejection: which regimen is best?

  2017cites this paper
• Research progress on humoral rejection after liver transplantation

  2017cites this paper
• Antibody-mediated rejection in the cardiac allograft: diagnosis, treatment and future considerations

  2017cites this paper
• The Current Status of Heart Transplantation

  2016influential citation
• Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts

  2016cites this paper
• Application of C4d Immunohistochemistry in ABO-Compatible and ABO-Incompatible Liver Transplantations

  2016cites this paper
• The CD8 T-cell response during tolerance induction in liver transplantation

  2016cites this paper
• Chapter 3 The Current Status of Heart Transplantation

  2015influential citation
• Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation

  2015cites this paper
• Title : Evaluation of an automated method for viability testing of lymphocytes for crossmatching before kidney transplantation and a retrospective evaluation of transplantation outcome

  2015influential citation
• The Role of Natural Killer Cells in Humoral Rejection

  2015cites this paper
• CORRELATION OF CORNEAL ALLOGRAFT REJECTION WITH TUMOR NECROSIS FACTORS-ALPHA GENE POLYMORPHISM

  2015cites this paper
• Analysis and monitoring of anti-HLA antibodies in solid-organ and stem cell transplantation : What to do? When should they be tested?

  2015cites this paper
• Heart Transplantation: New Realities, Challenges and Development- Demographics and Therapeutics

  2014cites this paper
• Clinical Allograft Rejection Syndromes in Liver Transplantation

  2014cites this paper
• Application of complement component 4d immunohistochemistry to ABO‐compatible and ABO‐incompatible liver transplantation

  2014cites this paper
• Aus der Klinik für Allgemein-, Viszeral- und Transplantationschirurgie der Medizinischen Fakultät Charité - Universitätsmedizin Berlin

  2014cites this paper
• Monitoring for HLA Antibody after Organ Transplantation

  2014cites this paper
• Antibody-mediated Rejection in Heart Transplantation

  2014cites this paper
• Red blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation

  2013cites this paper
• Acute antibody-mediated rejection after lung transplantation.

  2013cites this paper
• Learning from rejection: what transplantation teaches us about (other) vascular pathologies.

  2013cites this paper
• Nonsurgical Care of Intestinal and Multivisceral Transplant Recipients

  2013cites this paper
• Allograft Vasculopathy in Miniature Swine Effects of Mycophenolate Mofetil on Cardiac Allograft Survival and Cardiac

  2013cites this paper
• Pathological diagnosis of antibody-mediated rejection in renal allograft without c4d staining, how much reliable?

  2012cites this paper
• Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts

  2012cites this paper
• Der ELISA-basierte Nachweis von C4d nach Lebertransplantation - ein hilfreicher Marker zur Differentialdiagnose zwischen akuter Abstoßung und rezidivierender Hepatitis-C-Infektion?

  2012cites this paper
• The Histopathology of Lung Allograft Dysfunction Associated With the Development of Donor-specific HLA Alloantibodies

  2012cites this paper
• Antibody Mediated Rejection of the Cardiac Allograft

  2012cites this paper
• Lungentransplantation und Abstoßung

  2011cites this paper
• B Lymphocytes Differentially Influence Acute and Chronic Allograft Rejection in Mice

  2011cites this paper
• Antibody Testing Strategies for Deceased Donor Kidney Transplantation After Immunomodulatory Therapy

  2011cites this paper
• The Significance of Donor‐Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation

  2011cites this paper
• A Role for Antibodies to Human Leukocyte Antigens, Collagen-V, and K-&agr;1-Tubulin in Antibody-Mediated Rejection and Cardiac Allograft Vasculopathy

  2011cites this paper
• MiceAcute and Chronic Allograft Rejection in B Lymphocytes Differentially Influence

  2011cites this paper
• [Lung transplantation and rejection. Basic principles, clinical aspects and histomorphology].

  2011cites this paper
• Muromonab-CD3 for the successful treatment of early chronic rejection after pediatric liver transplantation: Report of a case

  2011cites this paper
• Acute and Chronic Rejection in Upper Extremity What Have We Learned

  2011cites this paper
• The strength of donor‐specific antibody is a more reliable predictor of antibody‐mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients

  2011cites this paper
• Chapter 15 – Immunohistology of the Pancreas, Biliary Tract, and Liver

  2011cites this paper
• Vascular endothelial growth factor-induced permeability in the pathogenesis of cardiac allograft vasculopathy

  2011cites this paper
• A Case of Late Mixed Acute Humoral and Cellular Rejection Successfully Treated with Rituximab, Plasmapheresis and IVIg

  2011cites this paper
• Acute and chronic rejection in upper extremity transplantation: what have we learned?

  2011cites this paper
• Compartmental Localization and Clinical Relevance of MICA Antibodies After Renal Transplantation

  2010cites this paper
• Human leukocyte antigen antibodies in liver retransplantation

  2010cites this paper
• Anticuerpos anti-HLA y rechazo agudo del injerto renal en los niños

  2010cites this paper
• Controversies in defining cardiac antibody-mediated rejection: need for updated criteria.

  2010cites this paper
• Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.

  2010cites this paper
• Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation.

  2010cites this paper
• A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection.

  2010cites this paper
• Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

  2010cites this paper
• ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?

  2010cites this paper
• Analysis of the IgVH genes in T cell-mediated and antibody-mediated rejection of the kidney graft

  2010cites this paper
• Can C4d Immunostaining on Endomyocardial Biopsies Be Considered a Prognostic Biomarker in Heart Transplant Recipients?

  2010cites this paper
• Protein A immunoadsorption combined with rituximab in highly sensitized kidney transplant recipients.

  2009cites this paper
• [New faces of acute rejection in 2008].

  2009cites this paper
• The prevalence of C4d-positive renal allografts in 134 consecutive biopsies in Thai patients.

  2009cites this paper
• Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

  2009cites this paper
• Acute antibody-mediated rejection after lung transplantation.

  2009cites this paper
• Graft vascular disease: immune response meets the vessel wall.

  2009influential citation
• Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection.

  2009cites this paper
• Therapeutic Plasma Exchange

  2009cites this paper
• An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases.

  2008cites this paper
• cute Antibody-mediated Rejection After Lung Transplantation

  2008cites this paper
• Pediatric Lung Transplantation: Perspectives for the Pathologist

  2008cites this paper
• Interstitial leukocytes in right ventricular endomyocardial biopsies after heart transplantation in patients with complicated versus uneventful postoperative course.

  2008cites this paper
• Monoclonal anti‐A antibody removal by synthetic A antigen immobilized on specific antibody filters

  2008cites this paper
• Cell Proliferation via the mTOR Pathway HLA Class I Antibody-Mediated Endothelial

  2008cites this paper
• C4d deposition is associated with chronic allograft nephropathy in rats and could be influenced by immunosuppressants.

  2008cites this paper
• Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.

  2008cites this paper
• HLA Class I Antibody-Mediated Endothelial Cell Proliferation via the mTOR Pathway1

  2008cites this paper
• The changing face of heart transplantation.

  2008cites this paper
• Anti-Human Leukocyte Antigen Antibodies, Vascular C4d Deposition and Increased Soluble C4d in Broncho-Alveolar Lavage of Lung Allografts

  2008cites this paper
• Evidence for no relevance of anti–major histocompatibility complex class i–related chain a antibodies in liver transplantation

  2008cites this paper
• Acceptable Donor-Specific Antibody Levels Allowing for Successful Deceased and Living Donor Kidney Transplantation After Desensitization Therapy

  2008cites this paper
• The problem of transplanting the sensitized patient: whose problem is it?

  2008influential citation
• Early and late humoral rejection: a clinicopathologic entity in two times.

  2008cites this paper
• [Today in molecular mechanisms of immunosuppressive drugs actions: roles of pharmacist].

  2008cites this paper
• Therapeutic plasma exchange performed in parallel with extra corporeal membrane oxygenation for antibody mediated rejection after heart transplantation

  2007cites this paper
• C4d immunopositivity is uncommon in ABO‐compatible liver allografts, but correlates partially with lymphocytotoxic antibody status

  2007cites this paper
• AVALIAÇÃO DA PRESENÇA DE ANTICORPOS ANTI- HLA NO PRIMEIRO ANO DO TRANSPLANTE RENAL

  2007cites this paper
• The Involvement of FcR Mechanisms in Antibody-Mediated Rejection

  2007cites this paper
• B cell depletion therapy in autoimmune diseases.

  2007cites this paper
• State-of-the-art strategies for immunosuppression

  2007cites this paper
• Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study.

  2007cites this paper
• The liver: a special case in transplantation tolerance.

  2007cites this paper
• Synergistic Deposition of C4d by Complement‐Activating and Non‐activating Antibodies in Cardiac Transplants

  2007cites this paper
• Contemporary concepts in noncellular rejection.

  2007cites this paper
• Humoral rejection in pediatric orthotopic heart transplantation.

  2007cites this paper
• Evaluation of C4d staining in liver and small intestine allografts.

  2006cites this paper